SEC Form 4Coverage since Jul 6, 2026
$ALMS insider trading
Over the last 12 months, Alumis insiders reported no purchases and 7 sales totaling $534K across SEC Form 4 filings.
- Bought · 12m
- — 0 events
- Sold · 12m
- $534K 7 events
- Events · 12m
- 7 Form 4 filings, grouped
- Insiders · 12m
- 6 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $ALMS · 12Mvia TradingView
Top insiders · 12m
Pangali SanamChief Legal Officer2× · $176K
Drappa JornChief Medical Officer1× · $65K
Bradley Mark ChristopherChief Development Officer1× · $68K
Goldstein David MChief Scientific Officer1× · $68K
Hardiman Roy C.Chief Business & Strategy Ofcr1× · $71K
All insider trades
7 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | Schroer John R.Chief Financial Officer · O | ▼ Sale | 3,282 | $26.37 | $87K | -11.7% | — |
| Aug 3, 2026 | Pangali SanamChief Legal Officer · O | ▼ Sale | 1,364 | $26.37 | $36K | -12.3% | — |
| Aug 3, 2026 | Hardiman Roy C.Chief Business & Strategy Ofcr · O | ▼ Sale | 2,692 | $26.37 | $71K | -1.3% | — |
| Aug 3, 2026 | Goldstein David MChief Scientific Officer · O | ▼ Sale | 2,596 | $26.37 | $68K | -7.7% | — |
| Aug 3, 2026 | Drappa JornChief Medical Officer · O | ▼ Sale | 2,447 | $26.37 | $65K | -4.1% | — |
| Aug 3, 2026 | Bradley Mark ChristopherChief Development Officer · O | ▼ Sale | 2,572 | $26.37 | $68K | -5% | — |
| Jul 6, 2026 | Pangali SanamChief Legal Officer · O | ▼ Sale | 5,000 | $28 | $140K | -31% | — |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $ALMS feed.